Casanova, L.M.; dos Santos Nascimento, L.B.; Costa, S.S. What Is New about Parsley, a Potential Source of Cardioprotective Therapeutic Substances? Nutraceuticals2024, 4, 104-126.
Casanova, L.M.; dos Santos Nascimento, L.B.; Costa, S.S. What Is New about Parsley, a Potential Source of Cardioprotective Therapeutic Substances? Nutraceuticals 2024, 4, 104-126.
Casanova, L.M.; dos Santos Nascimento, L.B.; Costa, S.S. What Is New about Parsley, a Potential Source of Cardioprotective Therapeutic Substances? Nutraceuticals2024, 4, 104-126.
Casanova, L.M.; dos Santos Nascimento, L.B.; Costa, S.S. What Is New about Parsley, a Potential Source of Cardioprotective Therapeutic Substances? Nutraceuticals 2024, 4, 104-126.
Abstract
Petroselinum crispum (Mill.) Fuss (Apiaceae), popularly known as parsley, is a ubiquitous aromatic herb used for culinary and medicinal purposes worldwide. Besides the richness in nutrients, sev-eral bioactive secondary metabolites, especially the flavone apigenin and its glycosides, have been described in the species. Parsley has already been shown to have several health-promoting activi-ties, such as antithrombotic, antihypertensive, and hypolipidemic. The multiple studies conducted in animal models so far suggest the species is a potential source of cardioprotective agents. This review provides up to date information and perspectives on the potential of parsley and its bioac-tive compounds for the development of nutraceutical products and drugs for the promotion of cardiovascular health. It includes not only a discussion on reported bioactivities, but also the knowledge of supplements and food additives developed as innovative parsley-based products.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
